Related Experiment Video
Updated: Oct 23, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia
Wenjia Lv1, Mengzhu Cao1, Jingju Liu1
1Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, National & Local United Engineering Laboratory for Power Batteries, Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Analysis and Testing Center, Department of Chemistry, Northeast Normal University, Changchun, Jilin Province 130024, China.
Abstract:
Reactive oxygen species (ROS)-mediated antitumor modalities that induced oxidative damage of cancer cells have recently acquired increasing attention on account of their noninvasiveness, low systemic toxicity, and high specificity. However, their clinical efficacy was often constrained by complex and various tumor microenvironment (TME), especially hypoxia characteristic and antioxidation effect of glutathione (GSH). Herein, we constructed a multinanozyme system based on hyaluronic acid (HA)-stabilized CuMnOx nanoparticles (CMOH) loaded with indocyanine green (ICG) with high-efficient ROS generation, O2 self-evolving function, GSH depletion ability and hyperthermia effect for achieving hypoxic tumor therapy. The CMOH nanozymes exhibited peroxidase-like and oxidase-like activities, which could efficiently catalyze H2O2 or O2 to generate hydroxyl radicals (•OH) or superoxide radicals (•O2-) in acidic tumor microenvironment (TME), elevating oxidative stress of tumor. Indocyanine green (ICG) was further loaded into HA-CuMnOx to form HA-CuMnOx@ICG nanocomposites (CMOI NCs), which can effectively generate singlet oxygen (1O2) and local hyperthermia under light irradiation. The hyperthermia generated by CMOI NCs further enhances the catalytic activities of nanozymes for ROS generation. Meanwhile, the CMOI with catalase-like activity could catalyze H2O2 into O2 for relieving tumor hypoxia and elevate O2-dependent ROS generation. Notably, CMOI can consume endogenous GSH, thereby impairing tumor antioxidant system and enhancing ROS-based therapy efficacy. After modified with HA, CMOI NCs with tumor targeting ability realized synergistic PTT-enhanced tumor oxidation therapy based on their multimodal properties. Thus, this work contributes to design high-performance therapeutic reagent to overcome the limitation of hypoxia and high antioxidant defense of tumor. STATEMENT OF SIGNIFICANCE: Reactive oxygen species (ROS)-mediated antitumor modalities were often constrained by complex and various tumor microenvironment (TME), especially hypoxia characteristic and antioxidation effect of glutathione (GSH). In this work, a multinanozyme system based on hyaluronic acid (HA)-stabilized CuMnOx nanoparticles (CMOH) loaded with indocyanine green (ICG) was designed to realize PTT-enhanced multiple catalysis tumor therapy. Although antitumor modalities based on multienzyme catalysis have been developed. Here, we highlighted the responsive catalysis of multienzyme system on tumor microenvironment (TME) and the promoting effect of photothermal effect on ROS production. Both in vitro and in vivo manifested that the enhanced anticancer efficacy of CMOI NCs due to their thermally amplified catalytic activity and TME regulation ability.
Insights
This study developed a novel nanozyme system that generates reactive oxygen species (ROS) to combat tumors. The system overcomes tumor hypoxia and glutathione defenses, enhancing cancer treatment efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Reactive oxygen species (ROS)-mediated antitumor therapies show promise due to low toxicity and high specificity.
- Clinical efficacy is limited by the tumor microenvironment (TME), particularly hypoxia and glutathione (GSH) antioxidant effects.
Purpose of the Study:
- To design a multinanozyme system to overcome TME limitations for enhanced cancer therapy.
- To develop a system with ROS generation, oxygen self-evolution, GSH depletion, and hyperthermia capabilities.
Main Methods:
- Constructed hyaluronic acid (HA)-stabilized CuMnOx nanoparticles (CMOH) loaded with indocyanine green (ICG).
- Investigated CMOH nanozymes' peroxidase-like and oxidase-like activities in acidic TME.
- Evaluated CMOI NCs' singlet oxygen generation, hyperthermia effect, catalase-like activity, and GSH consumption.
Main Results:
- CMOH nanozymes efficiently generated ROS (•OH, •O2−) in acidic TME.
- CMOI NCs produced singlet oxygen (1O2) and hyperthermia under light irradiation, enhancing ROS generation.
- CMOI NCs relieved tumor hypoxia by producing O2 and consumed GSH, boosting ROS-based therapy.
Conclusions:
- HA-modified CMOI NCs demonstrated synergistic photothermal therapy (PTT)-enhanced oxidation therapy.
- The developed nanozyme system effectively overcomes tumor hypoxia and high antioxidant defense.
- This work provides a high-performance therapeutic reagent for advanced cancer treatment.
More Related Videos
09:51One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...